Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination

Thidathip Wongsurawat; Piroon Jenjaroenpun; Kanokon Suwannasin; Natnicha Wankaew; Naphat Sanguansakpakdee; Thananya Amornpornviwat; Arjen M. Dondorp; Nicholas P. J. Day; François Nosten; Sir Nicholas White; Mallika Imwong

doi:10.1038/s41598-025-05065-2

Related publications

Article2015

Efficacy, safety and pharmacokinetics of KAF156 in adult patients with acute, uncomplicated P. falciparum or vivax malaria: a proof-of-concept, open label study

Sir Nicholas White, Kitipumi Chutasmit, Podjanee Jittamala, François Nosten, Aung Pyae Phyo, S. Pukrittayakamee, Đỗ Thị Thanh, Chirapong Uthaisin, R Li, Baldur Magnusson, Xiaolei Xun, Rui Zhao, Thierry T. Diagana, Peter Pertel, F. Joel Leong

Tropical Medicine & International Health

Letter1999

Naturally acquired immunity to vivax malaria

Christine Luxemburger, François Nosten, Sir Nicholas White

The Lancet

Article2008

Effects of Different Antimalarial Drugs on Gametocyte Carriage in P. Vivax Malaria

Sasithon Pukrittayakamee, Mallika Imwong, Pratap Singhasivanon, Kasia Stepniewska, Nicholas Day, Sir Nicholas White

American Journal of Tropical Medicine and Hygiene

Article2020

An educational guide for nanopore sequencing in the classroom

Article2001

Therapeutic responses to antibacterial drugs in vivax malaria

Sasithon Pukrittayakamee, Ralf Clemens, Arun Chantra, Apichart Nontprasert, Tanee Luknam, S Looareesuwan, Sir Nicholas White

Transactions of the Royal Society of Tropical Medicine and Hygiene